Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
44.4 EUR | -0.22% | +1.14% | -16.23% |
Mar. 28 | Roche Bobois S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 26 | Roche Bobois: 5% growth in annual sales | CF |
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock
- Equities
- Stock Roche Bobois S.A. - Euronext Paris
- Ratings Roche Bobois S.A.